SuperGen, Inc. To Present At First Albany Capital Annual Growth Conference

DUBLIN, Calif., Dec. 5 /PRNewswire-FirstCall/ -- SuperGen, Inc. today announced that James S. Manuso, Ph.D., President and Chief Executive Officer is scheduled to present at the First Albany Capital Annual Growth Conference, being held at the Mandarin Oriental Hotel in New York on Tuesday, December 6, 2005, at 8:00 a.m. ET. Dr. Manuso will provide a brief corporate overview and discuss the Company's recent progress. A live webcast of the presentation will be available on the Investor Relations section of the Company's website at http://www.supergen.com. The webcast will be archived for 90 days.

About SuperGen

Based in Dublin, California, SuperGen is a pharmaceutical company dedicated to the acquisition, rapid development and commercialization of therapies for solid tumors, hematological malignancies and blood disorders. SuperGen's product portfolio includes Nipent(R) (pentostatin for injection); Mitomycin (generic brand of Mutamycin(R)); and SurfaceSafe(R) cleaner.

For more information about SuperGen, please visit http://www.supergen.com. Contacts: Timothy L. Enns Sharon Weinstein SuperGen, Inc. Noonan Russo Tel: (925) 560-0100 x111 Tel: (212) 845-4271 E-mail: tenns@supergen.com E-mail: sharon.weinstein@eurorscg.com

SuperGen, Inc.

CONTACT: Timothy L. Enns of SuperGen, Inc., +1-925-560-0100 ext. 111,tenns@supergen.com; or Sharon Weinstein of Noonan Russo, for SuperGen,Inc., +1-212-845-4271, sharon.weinstein@eurorscg.com

Back to news